CD66a, also known as CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1), is a glycoprotein belonging to the immunoglobulin superfamily. It plays a role in multiple cellular activities such as differentiation and arrangement of tissue three-dimensional structure, angiogenesis, apoptosis, tumor suppression, metastasis, and the modulation of innate and adaptive immune responses. It can be found expressed on the surface of endothelial/epithelial cells, neutrophils, and monocytes and can be induced on T cells, B cells, and CD16-negative NK cells. In hematopoietic cells, its expression is found abundantly on B cells as well as some NKs, monocytes, DCs, and granulocytes.
Anti-Human CD66a/CEACAM1 (CD66a-B1.1)-149Sm—100 Tests